• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.

作者信息

Bonadonna G, Zucali R, De Lena M, Valagussa P

出版信息

Cancer Treat Rep. 1977 Aug;61(5):769-77.

PMID:70270
Abstract
摘要

相似文献

1
Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.晚期霍奇金病的联合化疗（MOPP或ABVD）-放疗方法。
Cancer Treat Rep. 1977 Aug;61(5):769-77.
2
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.多柔比星、博来霉素、长春碱和达卡巴嗪（ABVD）挽救性治疗对氮芥、长春新碱、泼尼松和丙卡巴肼（MOPP）耐药的晚期霍奇金淋巴瘤。
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):947-51.
3
ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.霍奇金淋巴瘤中ABVD方案治疗MOPP方案失败病例：对挽救性治疗目标的重新审视
Cancer Treat Rep. 1978 Mar;62(3):363-7.
4
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.霍奇金淋巴瘤放疗失败后的挽救性化疗：含阿霉素方案优于MOPP方案。
Cancer Treat Rep. 1986 Mar;70(3):343-8.
5
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.ABVD方案与MOPP/ABV混合方案治疗晚期霍奇金淋巴瘤的随机对照研究：一项多组间试验报告
J Clin Oncol. 2003 Feb 15;21(4):607-14. doi: 10.1200/JCO.2003.12.086.
6
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].国际预后评分在晚期霍奇金淋巴瘤预后预测中的应用可行性研究
Ai Zheng. 2006 Aug;25(8):1013-8.
7
Pediatric Hodgkin's disease.小儿霍奇金病
J Ky Med Assoc. 2004 Mar;102(3):104-6.
8
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.八药联合化疗（MOPP和ABDV）及局部放疗用于晚期霍奇金病
Cancer Treat Rep. 1976 Sep;60(9):1217-23.
9
[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].[癌症的成功化疗。霍奇金病的缓解。IV]
Clin Ter. 2001 May-Jun;152(3):203-6.
10
Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.初治晚期霍奇金病患者的综合治疗：一项24年随访研究
Cancer J Sci Am. 1995 Nov-Dec;1(4):267-73.

引用本文的文献

1
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.正电子发射断层扫描（PET）对淋巴瘤患者预后的预测作用。
Br J Cancer. 2004 Aug 31;91(5):850-4. doi: 10.1038/sj.bjc.6602040.
2
Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.长春地辛在51例人类实体瘤联合化疗中的神经毒性。
Cancer Chemother Pharmacol. 1981;6(2):175-81. doi: 10.1007/BF00262339.
3
[Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].ABVD 治疗对 C-MOPP 耐药的霍奇金病的结果（作者译）
Klin Wochenschr. 1981 Mar 16;59(6):267-73. doi: 10.1007/BF01478205.
4
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.使用ChlVPP的五年经验：霍奇金病的有效低毒联合化疗
Br J Cancer. 1982 Jun;45(6):851-9. doi: 10.1038/bjc.1982.137.
5
Prognostic factors in COPP-treated patients with Hodgkin's disease.接受COPP治疗的霍奇金病患者的预后因素。
Blut. 1982 Jun;44(6):339-48. doi: 10.1007/BF00319917.
6
[A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].一种改良的MOPP方案治疗ⅢB和Ⅳ期霍奇金病（作者译）
Blut. 1978 Aug 15;37(2):83-8. doi: 10.1007/BF01002106.
7
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).用阿霉素、博来霉素、长春花碱和达卡巴嗪（ABVD）治疗后，MOPP耐药的霍奇金病患者获得长期无病生存。
Cancer Chemother Pharmacol. 1979;2(2):101-5. doi: 10.1007/BF00254081.
8
Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).
Cancer Chemother Pharmacol. 1979;2(3):209-13. doi: 10.1007/BF00258297.